Bone mineral metabolism in patients with chronic kidney disease on dialysis in Southern Metropolitan Santiago

被引:2
作者
Ruiz de Arechavaleta, Andrea [1 ]
Quintero, Nerio [2 ]
Daniela Parra, E. U. [2 ]
Jara, Aquiles [3 ]
Russo, Moises [4 ]
Zitko, Pedro [5 ]
Pefaur, Jacqueline [6 ]
机构
[1] Univ Chile, Programa Especializac Nefrol, Santiago, Chile
[2] Hosp Barros Luco, Unidad Hemodialisis, Santiago, Chile
[3] Pontificia Univ Catolica Chile, Dept Nefrol, Santiago, Chile
[4] Univ Diego Portales, Fac Med, Santiago, Chile
[5] Hosp Barros Luco, Unidad Estudios Asistenaciales, Santiago, Chile
[6] Hosp Barros Luco, Dept Nefrol, Santiago, Chile
关键词
Hypocalcemia; Metabolism; Parathyroid hormone; Renal analysis; Standards; CLINICAL-PRACTICE GUIDELINES; SERUM-CALCIUM; HEMODIALYSIS; MORTALITY; OUTCOMES; PTH; PHOSPHORUS; RISK; ASSOCIATION; MANAGEMENT;
D O I
10.4067/S0034-98872015000200003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) is a condition of dialysis patients associated with both morbidity and mortality. Management is based on clinical guidelines with goals that are hard to comply with. Aim: To describe and compare biochemical variables associated with this disorder in two different time periods. Material and Methods: Revision of medical records of 814 patients (49% females) dialyzed during 2009 and 1018 patients (48% females), dialyzed during 2012 in Southern Metropolitan Santiago. Information about serum calcium, phosphorus, parathyroid hormone (PTH) and albumin was retrieved. Results: Median PTH values in 2009 and 2012 were 222.5 and 353.5 pg/ml respectively (p < 0.05). The figures for serum calcium corrected by albumin were 9.0 and 8.5 mg/dl respectively (p < 0.05). The figures for phosphorus were 4.7 and 5.0 mg/dl respectively (p < 0.05). The Calcium x Phosphorus product was 41.4 and 42.5 mg(2)/dl(2) (p < 0.05). Of note, the proportion patients with serum calcium below recommended levels (< 8.4 mg/dl) increased from 16% to 40% from 2009 to 2012. The proportion of patients with biochemical variables within recommended ranges was lower in 2012 than in 2009. Conclusions: There was a low proportion of patients with bone metabolism parameters within ranges recommended by clinical guidelines. These parameters were worst in 2012.
引用
收藏
页码:168 / 174
页数:7
相关论文
共 27 条
  • [1] Achieving K/DOQI laboratory target values for bone and mineral metabolism:: An uphill battle
    Al Aly, Z
    González, EA
    Martin, KJ
    Gellens, ME
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (04) : 422 - 426
  • [2] Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease:: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units
    Arenas, M. Dolores
    Alvarez-Ude, Fernando
    Gil, M. Teresa
    Soriano, Antonio
    Egea, Juan Jose
    Millan, Isabel
    Amoedo, M. Luisa
    Muray, Salome
    Carreton, M. Antonia
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (06) : 1663 - 1668
  • [3] Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
    Block, GA
    Klassen, PS
    Lazarus, JM
    Ofsthun, N
    Lowrie, EG
    Chertow, GM
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08): : 2208 - 2218
  • [4] Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients
    Braun, J
    Oldendorf, M
    Moshage, W
    Heidler, R
    Zeitler, E
    Luft, FC
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) : 394 - 401
  • [5] High prevalence of secondary hyperparathyroidism in chronic kidney disease patients on dialysis in Argentina
    Douthat, Walter G.
    Castellano, Mauro
    Berenguer, Leandro
    Alejandra Guzman, M.
    de Arteaga, Javier
    Chiurchiu, Carlos R.
    Massari, Pablo U.
    Garay, Gabriela
    Capra, Raul
    de la Fuente, Jorge L.
    [J]. NEFROLOGIA, 2013, 33 (05): : 657 - 666
  • [6] On the evolving nature of understanding dialysis-related disorders
    Eknoyan, G
    Lindberg, JS
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) : S1 - S3
  • [7] FERNANDEZ E, 1995, J AM SOC NEPHROL, V6, P132
  • [8] Are the K/DOQI objectives for bone mineral alterations in stage 3-5 chronic kidney disease patients unreachable or inadequate?
    Fernandez, Elvira
    [J]. NEFROLOGIA, 2013, 33 (01): : 1 - 6
  • [9] Hypocalcemia, morbidity, and mortality in end-stage renal disease
    Foley, RN
    Parfrey, PS
    Harnett, JD
    Kent, GM
    Hu, LQ
    ODea, R
    Murray, DC
    Barre, PE
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1996, 16 (05) : 386 - 393
  • [10] Fournier A, 1994, Curr Opin Nephrol Hypertens, V3, P396, DOI 10.1097/00041552-199407000-00005